EP1150673A4 - Mono-acyloxy aralkyl neuromuscular relaxants - Google Patents

Mono-acyloxy aralkyl neuromuscular relaxants

Info

Publication number
EP1150673A4
EP1150673A4 EP00904621A EP00904621A EP1150673A4 EP 1150673 A4 EP1150673 A4 EP 1150673A4 EP 00904621 A EP00904621 A EP 00904621A EP 00904621 A EP00904621 A EP 00904621A EP 1150673 A4 EP1150673 A4 EP 1150673A4
Authority
EP
European Patent Office
Prior art keywords
acyloxy
aralkyl
mono
neuromuscular relaxants
relaxants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00904621A
Other languages
German (de)
French (fr)
Other versions
EP1150673A1 (en
Inventor
Chingmuh Lee
Laszlo Gyermek
Young-Moon Cho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Newlaxant LLC
Original Assignee
Newlaxant LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newlaxant LLC filed Critical Newlaxant LLC
Publication of EP1150673A1 publication Critical patent/EP1150673A1/en
Publication of EP1150673A4 publication Critical patent/EP1150673A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
EP00904621A 1999-02-01 2000-01-31 Mono-acyloxy aralkyl neuromuscular relaxants Withdrawn EP1150673A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11839299P 1999-02-01 1999-02-01
US118392P 1999-02-01
PCT/US2000/002228 WO2000044377A1 (en) 1999-02-01 2000-01-31 Mono-acyloxy aralkyl neuromuscular relaxants

Publications (2)

Publication Number Publication Date
EP1150673A1 EP1150673A1 (en) 2001-11-07
EP1150673A4 true EP1150673A4 (en) 2002-04-24

Family

ID=22378296

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00904621A Withdrawn EP1150673A4 (en) 1999-02-01 2000-01-31 Mono-acyloxy aralkyl neuromuscular relaxants

Country Status (21)

Country Link
EP (1) EP1150673A4 (en)
JP (1) JP2002535366A (en)
KR (1) KR20010108125A (en)
CN (1) CN1338934A (en)
AR (1) AR022472A1 (en)
AU (1) AU2634900A (en)
BR (1) BR0007863A (en)
CA (1) CA2360790A1 (en)
CO (1) CO5170470A1 (en)
CZ (1) CZ20012780A3 (en)
HK (1) HK1039455A1 (en)
HU (1) HUP0200413A3 (en)
IL (1) IL144249A0 (en)
MX (1) MXPA01007783A (en)
NO (1) NO20013741L (en)
NZ (1) NZ513064A (en)
PE (1) PE20001593A1 (en)
PL (1) PL349099A1 (en)
TR (1) TR200102196T2 (en)
WO (1) WO2000044377A1 (en)
ZA (1) ZA200105882B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746964A (en) * 1953-11-02 1956-05-22 Lakeside Lab Inc Dicarboxylic acid esters of nu-alkyl-3-hydroxypiperidine and salts thereof
AT292702B (en) * 1968-12-29 1971-09-10 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of new N-methyl-piperidine derivatives and the acid addition salts and the onium derivatives of these compounds
US5494898A (en) * 1991-02-13 1996-02-27 Ohmeda Pharmaceutical Products Division Inc. Peptide skeletal muscle relaxants
US5990124A (en) * 1997-10-24 1999-11-23 Gyermek; Laszlo Neuromuscular relaxants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
L. GYERMEK, C. LEE, N. NGUYEN: "Pharmacology of G-1-64, a new nondepolarizing neuromuscular blocking agent with rapid onset and short duration of action", ACTA ANAESTHESIOLOGICA SCANDINAVICA, XX, XX, vol. 43, no. 6, July 1999 (1999-07-01), pages 651 - 657, XP001056943, ISSN: 0001-5172 *

Also Published As

Publication number Publication date
PL349099A1 (en) 2002-07-01
EP1150673A1 (en) 2001-11-07
CO5170470A1 (en) 2002-06-27
KR20010108125A (en) 2001-12-07
NO20013741L (en) 2001-09-19
HUP0200413A3 (en) 2002-11-28
AU2634900A (en) 2000-08-18
BR0007863A (en) 2001-11-06
JP2002535366A (en) 2002-10-22
WO2000044377A1 (en) 2000-08-03
HK1039455A1 (en) 2002-04-26
CA2360790A1 (en) 2000-08-03
TR200102196T2 (en) 2002-01-21
PE20001593A1 (en) 2001-01-16
NO20013741D0 (en) 2001-07-31
CN1338934A (en) 2002-03-06
ZA200105882B (en) 2003-02-18
CZ20012780A3 (en) 2002-01-16
HUP0200413A2 (en) 2002-06-29
NZ513064A (en) 2003-08-29
IL144249A0 (en) 2002-05-23
MXPA01007783A (en) 2002-08-20
AR022472A1 (en) 2002-09-04

Similar Documents

Publication Publication Date Title
DE60033307D1 (en) Heteroalkylamino-substituierte bicyclische stickstoffheterocyclen
DE50002490D1 (en) Polyester-polyetherblockcopolymere
GB0029386D0 (en) Not known at present
PL357601A1 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines
GB0029389D0 (en) Not known at present
GB9903584D0 (en) Modified calycins
DE60028360D1 (en) Ptk-chipthermistor
GB2347186B (en) Improved nail
DE60012950D1 (en) Polyacetalharzzusammensetzung
GB2356125B (en) Ensilage
GB2352957B (en) Numnah
HK1046280B (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-derivatives
GB9913742D0 (en) Horologe improvement
GB9914798D0 (en) Ensure
DE50008219D1 (en) Common-rail-injektor
PL349099A1 (en) Mono-acyloxy aralkyl neuromuscular relaxants
DE60007846D1 (en) Sterndreieckschalter
GB0026973D0 (en) Thjreaded fasteners
HU0000970D0 (en) Rapid fastening set
TW433433U (en) Improved lampstand
HK1048362A1 (en) Optomodule
EG22401A (en) Set 3c1-strong
CA86740S (en) Bus
GB9914563D0 (en) R s c
TW420259U (en) Connection strcutural improvement

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010903

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020311

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/397 A, 7A 61K 31/403 B, 7A 61K 31/439 B, 7A 61K 31/4025 B, 7A 61K 31/4545 B, 7A 61K 31/55 B, 7C 07D 211/46 B, 7C 07D 223/08 B, 7C 07D 295/04 B

17Q First examination report despatched

Effective date: 20020710

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031007

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1039455

Country of ref document: HK